SGH
ASND icon

Sivik Global Healthcare’s Ascendis Pharma A/S ASND Stock Holding History

Sivik Global Healthcare’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$1.49M – 39
2024
Q3 		$1.49M Buy
+10,000
New +$1.35M 0.63% 33

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Sivik Global Healthcare's ASND Position: Q4 2024 in Review

Sivik Global Healthcare sold out of Ascendis Pharma A/S (ASND) in Q4 2024, closing a stake of 10,000 shares — an estimated $1.49M sold.

Sivik Global Healthcare first reported a position in ASND in Q3 2024 and held it in 1 quarter. The position peaked at $1.49M in Q3 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.

  • Sivik Global Healthcare reported no remaining Ascendis Pharma A/S position as of Q4 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 10,000 Ascendis Pharma A/S shares in Q4 2024, an estimated $1.49M.
  • Sivik Global Healthcare first reported a position in Ascendis Pharma A/S in Q3 2024 and held it in 1 quarter.
  • Sivik Global Healthcare's Ascendis Pharma A/S position peaked at $1.49M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2024.

Based on Sivik Global Healthcare's 13F filing for Q4 2024, filed 23 Jan 2025.